US Physicalrapy (NYSE: USPH) — Company Overview, News & Financial Data
US Physical Therapy operates outpatient clinics in the U.S., focusing on personalized rehabilitation services.
US Physicalrapy
US Physical Therapy (NYSE:USPH) operates an expansive network of outpatient physical therapy clinics across the United States. Specializing in the rehabilitation of musculoskeletal injuries and conditions, the company focuses on providing personalized physical therapy services aimed at improving patients' quality of life. US Physical Therapy's projects include expanding its geographical footprint through the acquisition of existing clinics and the opening of new locations, leveraging partnerships with healthcare professionals to enhance service delivery. The company's objective is to become the preferred provider of outpatient physical therapy services by ensuring high-quality care, embracing innovative treatment methods, and fostering a culture of excellence and patient satisfaction.
Snapshot
Operations
Products and/or services of US Physicalrapy
- Outpatient physical therapy services, offering personalized treatment plans for rehabilitation and injury prevention.
- Workforce performance solutions, specializing in injury prevention and management for employees.
- Occupational therapy, providing treatments to enhance patients' ability to perform daily activities.
- Sports medicine services, offering advanced care and rehabilitation for athletes.
- Specialized services for senior citizens to improve mobility and manage chronic pain.
- Pediatric therapy services focused on developmental, neuromuscular, and orthopedic conditions in children.
US Physicalrapy executive team
- Christopher J. ReadingCEO & Chairman
- Eric Joseph WilliamsPresident & COO
- Richard S. BinsteinExecutive VP, General Counsel & Secretary
- Graham D. ReeveChief Operating Officer - West
- Michael G. MayrsohnCEO of Metro & Director
- Nchacha E. EttaExecutive VP & CFO
Dividend history
Dividends per share paid by US Physicalrapy, by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2026(to date) | — | — | — | $1.3800 |
| FY2025 | — | — | — | $1.8000 |
| FY2024 | — | — | — | $1.7600 |
| FY2023 | — | — | — | $1.7200 |
| FY2022 | — | — | — | $1.6400 |
Key financials
Reported results for US Physicalrapy, in USD.
- Market cap
- 1.3B
- Revenue (TTM)
- 804.3M
- P/E ratio
- 470.8
- EPS (diluted, TTM)
- 0.2
- Dividend yield
- 2.1%
- Profit margin
- 4.0%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 781M | 80.4M | 15.1M | |
| 671.3M | 63.2M | 26.5M | |
| 604.8M | 52.1M | 14.7M | |
| 553.1M | 56.8M | 28.3M |